Lipo C Protocol | $179/mo
US$ 28.28
bpc 157 legal status us fda π¬ BIG NEWS in compounded peptide therapy. On February 27, HHS Secretary RFK Jr. announced his intent to move ~14 of 19 previously restricted peptides back to compounding β meaning bpc-157 fda warning 2025 september
Description
These medications include: Oxybutynin (Ditropan XL) Mirabegron (Myrbetriq) Tolterodine (Detrol) Solifenacin (Vesicare) Vibegron (Gemtesa) In older adults, the side effects of Ditropan, Detrol, and Vesicare may include dry mouth, constipation, blurred vision, and confusion
Brocks et al
I offered that if these things are signs that the vaccine is working then perhaps when the body slows down making antibodies or T cells maybe this goes away as well
It also acts as an antiseptic
